|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:INPP5F-GRK5 (FusionGDB2 ID:39843) |
Fusion Gene Summary for INPP5F-GRK5 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: INPP5F-GRK5 | Fusion gene ID: 39843 | Hgene | Tgene | Gene symbol | INPP5F | GRK5 | Gene ID | 22876 | 2869 |
| Gene name | inositol polyphosphate-5-phosphatase F | G protein-coupled receptor kinase 5 | |
| Synonyms | MSTP007|MSTPO47|SAC2|hSAC2 | FP2025|GPRK5 | |
| Cytomap | 10q26.11 | 10q26.11 | |
| Type of gene | protein-coding | protein-coding | |
| Description | phosphatidylinositide phosphatase SAC2Sac domain-containing inositol phosphatase 2sac domain-containing phosphoinositide 4-phosphatase 2sac domain-containing phosphoinositide 5-phosphatase 2 | G protein-coupled receptor kinase 5g protein-coupled receptor kinase GRK5 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q9Y2H2 | P34947 | |
| Ensembl transtripts involved in fusion gene | ENST00000361976, ENST00000369083, ENST00000369080, ENST00000369081, ENST00000490818, | ENST00000369108, ENST00000473264, ENST00000392870, | |
| Fusion gene scores | * DoF score | 5 X 4 X 4=80 | 19 X 19 X 6=2166 |
| # samples | 5 | 19 | |
| ** MAII score | log2(5/80*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(19/2166*10)=-3.51096191927738 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: INPP5F [Title/Abstract] AND GRK5 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | INPP5F(121485871)-GRK5(121140327), # samples:3 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | INPP5F | GO:0001921 | positive regulation of receptor recycling | 25869669 |
| Hgene | INPP5F | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein | 25476455 |
| Hgene | INPP5F | GO:0046856 | phosphatidylinositol dephosphorylation | 11274189|25869669 |
| Tgene | GRK5 | GO:0007217 | tachykinin receptor signaling pathway | 17986524 |
| Tgene | GRK5 | GO:0043066 | negative regulation of apoptotic process | 20124405 |
| Tgene | GRK5 | GO:0046777 | protein autophosphorylation | 14976207 |
| Fusion gene breakpoints across INPP5F (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across GRK5 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | SKCM | TCGA-FS-A1ZD-06A | INPP5F | chr10 | 121485871 | - | GRK5 | chr10 | 121140327 | + |
| ChimerDB4 | SKCM | TCGA-FS-A1ZD-06A | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + |
Top |
Fusion Gene ORF analysis for INPP5F-GRK5 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000361976 | ENST00000369108 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + |
| 5CDS-5UTR | ENST00000369083 | ENST00000369108 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + |
| 5CDS-intron | ENST00000361976 | ENST00000473264 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + |
| 5CDS-intron | ENST00000369083 | ENST00000473264 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + |
| In-frame | ENST00000361976 | ENST00000392870 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + |
| In-frame | ENST00000369083 | ENST00000392870 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + |
| intron-3CDS | ENST00000369080 | ENST00000392870 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + |
| intron-3CDS | ENST00000369081 | ENST00000392870 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + |
| intron-3CDS | ENST00000490818 | ENST00000392870 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + |
| intron-5UTR | ENST00000369080 | ENST00000369108 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + |
| intron-5UTR | ENST00000369081 | ENST00000369108 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + |
| intron-5UTR | ENST00000490818 | ENST00000369108 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + |
| intron-intron | ENST00000369080 | ENST00000473264 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + |
| intron-intron | ENST00000369081 | ENST00000473264 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + |
| intron-intron | ENST00000490818 | ENST00000473264 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000369083 | INPP5F | chr10 | 121485871 | + | ENST00000392870 | GRK5 | chr10 | 121140327 | + | 2440 | 263 | 166 | 1887 | 573 |
| ENST00000361976 | INPP5F | chr10 | 121485871 | + | ENST00000392870 | GRK5 | chr10 | 121140327 | + | 2440 | 263 | 166 | 1887 | 573 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000369083 | ENST00000392870 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + | 0.003344353 | 0.9966556 |
| ENST00000361976 | ENST00000392870 | INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140327 | + | 0.003344353 | 0.9966556 |
Top |
Fusion Genomic Features for INPP5F-GRK5 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140326 | + | 8.43E-10 | 1 |
| INPP5F | chr10 | 121485871 | + | GRK5 | chr10 | 121140326 | + | 8.43E-10 | 1 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for INPP5F-GRK5 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr10:121485871/chr10:121140327) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| INPP5F | GRK5 |
| FUNCTION: Inositol 4-phosphatase which mainly acts on phosphatidylinositol 4-phosphate. May be functionally linked to OCRL, which converts phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol, for a sequential dephosphorylation of phosphatidylinositol 4,5-bisphosphate at the 5 and 4 position of inositol, thus playing an important role in the endocytic recycling (PubMed:25869669). Regulator of TF:TFRC and integrins recycling pathway, is also involved in cell migration mechanisms (PubMed:25869669). Modulates AKT/GSK3B pathway by decreasing AKT and GSK3B phosphorylation (PubMed:17322895). Negatively regulates STAT3 signaling pathway through inhibition of STAT3 phosphorylation and translocation to the nucleus (PubMed:25476455). Functionally important modulator of cardiac myocyte size and of the cardiac response to stress (By similarity). May play a role as negative regulator of axon regeneration after central nervous system injuries (By similarity). {ECO:0000250|UniProtKB:Q8CDA1, ECO:0000269|PubMed:17322895, ECO:0000269|PubMed:25476455, ECO:0000269|PubMed:25869669}. | FUNCTION: Serine/threonine kinase that phosphorylates preferentially the activated forms of a variety of G-protein-coupled receptors (GPCRs). Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their down-regulation. Phosphorylates a variety of GPCRs, including adrenergic receptors, muscarinic acetylcholine receptors (more specifically Gi-coupled M2/M4 subtypes), dopamine receptors and opioid receptors. In addition to GPCRs, also phosphorylates various substrates: Hsc70-interacting protein/ST13, TP53/p53, HDAC5, and arrestin-1/ARRB1. Phosphorylation of ARRB1 by GRK5 inhibits G-protein independent MAPK1/MAPK3 signaling downstream of 5HT4-receptors. Phosphorylation of HDAC5, a repressor of myocyte enhancer factor 2 (MEF2) leading to nuclear export of HDAC5 and allowing MEF2-mediated transcription. Phosphorylation of TP53/p53, a crucial tumor suppressor, inhibits TP53/p53-mediated apoptosis. Phosphorylation of ST13 regulates internalization of the chemokine receptor. Phosphorylates rhodopsin (RHO) (in vitro) and a non G-protein-coupled receptor, LRP6 during Wnt signaling (in vitro). {ECO:0000269|PubMed:19661922, ECO:0000269|PubMed:19801552, ECO:0000269|PubMed:20038610, ECO:0000269|PubMed:20124405, ECO:0000269|PubMed:21728385}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | GRK5 | chr10:121485871 | chr10:121140327 | ENST00000392870 | 1 | 16 | 186_448 | 49 | 591.0 | Domain | Protein kinase | |
| Tgene | GRK5 | chr10:121485871 | chr10:121140327 | ENST00000392870 | 1 | 16 | 449_514 | 49 | 591.0 | Domain | AGC-kinase C-terminal | |
| Tgene | GRK5 | chr10:121485871 | chr10:121140327 | ENST00000392870 | 1 | 16 | 53_171 | 49 | 591.0 | Domain | RGS | |
| Tgene | GRK5 | chr10:121485871 | chr10:121140327 | ENST00000392870 | 1 | 16 | 388_395 | 49 | 591.0 | Motif | Nuclear localization signal | |
| Tgene | GRK5 | chr10:121485871 | chr10:121140327 | ENST00000392870 | 1 | 16 | 192_200 | 49 | 591.0 | Nucleotide binding | ATP | |
| Tgene | GRK5 | chr10:121485871 | chr10:121140327 | ENST00000392870 | 1 | 16 | 546_565 | 49 | 591.0 | Region | Note=Sufficient for membrane localization |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | INPP5F | chr10:121485871 | chr10:121140327 | ENST00000361976 | + | 1 | 20 | 167_518 | 32 | 1133.0 | Domain | SAC |
| Hgene | INPP5F | chr10:121485871 | chr10:121140327 | ENST00000361976 | + | 1 | 20 | 593_760 | 32 | 1133.0 | Domain | hSac2 |
| Hgene | INPP5F | chr10:121485871 | chr10:121140327 | ENST00000369080 | + | 1 | 6 | 167_518 | 0 | 523.0 | Domain | SAC |
| Hgene | INPP5F | chr10:121485871 | chr10:121140327 | ENST00000369080 | + | 1 | 6 | 593_760 | 0 | 523.0 | Domain | hSac2 |
| Hgene | INPP5F | chr10:121485871 | chr10:121140327 | ENST00000369083 | + | 1 | 10 | 167_518 | 32 | 376.0 | Domain | SAC |
| Hgene | INPP5F | chr10:121485871 | chr10:121140327 | ENST00000369083 | + | 1 | 10 | 593_760 | 32 | 376.0 | Domain | hSac2 |
| Tgene | GRK5 | chr10:121485871 | chr10:121140327 | ENST00000392870 | 1 | 16 | 1_185 | 49 | 591.0 | Region | Note=N-terminal |
Top |
Fusion Gene Sequence for INPP5F-GRK5 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >39843_39843_1_INPP5F-GRK5_INPP5F_chr10_121485871_ENST00000361976_GRK5_chr10_121140327_ENST00000392870_length(transcript)=2440nt_BP=263nt TCTCCTCCTACCGGTCGGGTGCCCCGGGGCGTTCCCTCTGCCGCTGCTTCTCGGCGCGGTTCCTACCCGGCCGCTCCCCGAGGCGCGGGC TCTGGCGGCCTCGACCGACTAGGACGCCCCGTGCGCCGCCCGCGGGCCGCCGCCTCCCTGGGCGCGCGGGGCCAGCATGGAGCTCTTCCA AGCCAAGGACCACTACATCCTGCAGCAGGGCGAGCGCGCGCTGTGGTGCAGCCGCCGCGACGGCGGCCTCCAGCTCCGACCCGACAGAGA TTACTGCAGTTTATGTGACAAGCAGCCAATCGGGAGGCTGCTTTTCCGGCAGTTTTGTGAAACCAGGCCTGGGCTGGAGTGTTACATTCA GTTCCTGGACTCCGTGGCAGAATATGAAGTTACTCCAGATGAAAAACTGGGAGAGAAAGGGAAGGAAATTATGACCAAGTACCTCACCCC AAAGTCCCCTGTTTTCATAGCCCAAGTTGGCCAAGACCTGGTCTCCCAGACGGAGGAGAAGCTCCTACAGAAGCCGTGCAAAGAACTCTT TTCTGCCTGTGCACAGTCTGTCCACGAGTACCTGAGGGGAGAACCATTCCACGAATATCTGGACAGCATGTTTTTTGACCGCTTTCTCCA GTGGAAGTGGTTGGAAAGGCAACCGGTGACCAAAAACACTTTCAGGCAGTATCGAGTGCTAGGAAAAGGGGGCTTCGGGGAGGTCTGTGC CTGCCAGGTTCGGGCCACGGGTAAAATGTATGCCTGCAAGCGCTTGGAGAAGAAGAGGATCAAAAAGAGGAAAGGGGAGTCCATGGCCCT CAATGAGAAGCAGATCCTCGAGAAGGTCAACAGTCAGTTTGTGGTCAACCTGGCCTATGCCTACGAGACCAAGGATGCACTGTGCTTGGT CCTGACCATCATGAATGGGGGTGACCTGAAGTTCCACATCTACAACATGGGCAACCCTGGCTTCGAGGAGGAGCGGGCCTTGTTTTATGC GGCAGAGATCCTCTGCGGCTTAGAAGACCTCCACCGTGAGAACACCGTCTACCGAGATCTGAAACCTGAAAACATCCTGTTAGATGATTA TGGCCACATTAGGATCTCAGACCTGGGCTTGGCTGTGAAGATCCCCGAGGGAGACCTGATCCGCGGCCGGGTGGGCACTGTTGGCTACAT GGCTCCAGAGGTCCTGAACAACCAGAGGTACGGCCTGAGCCCCGACTACTGGGGCCTTGGCTGCCTCATCTATGAGATGATCGAGGGCCA GTCGCCGTTCCGCGGCCGCAAGGAGAAGGTGAAGCGGGAGGAGGTGGACCGCCGGGTCCTGGAGACGGAGGAGGTGTACTCCCACAAGTT CTCCGAGGAGGCCAAGTCCATCTGCAAGATGCTGCTCACGAAAGATGCGAAGCAGAGGCTGGGCTGCCAGGAGGAGGGGGCTGCAGAGGT CAAGAGACACCCCTTCTTCAGGAACATGAACTTCAAGCGCTTAGAAGCCGGGATGTTGGACCCTCCCTTCGTTCCAGACCCCCGCGCTGT GTACTGTAAGGACGTGCTGGACATCGAGCAGTTCTCCACTGTGAAGGGCGTCAATCTGGACCACACAGACGACGACTTCTACTCCAAGTT CTCCACGGGCTCTGTGTCCATCCCATGGCAAAACGAGATGATAGAAACAGAATGCTTTAAGGAGCTGAACGTGTTTGGACCTAATGGTAC CCTCCCGCCAGATCTGAACAGAAACCACCCTCCGGAACCGCCCAAGAAAGGGCTGCTCCAGAGACTCTTCAAGCGGCAGCATCAGAACAA TTCCAAGAGTTCGCCCAGCTCCAAGACCAGTTTTAACCACCACATAAACTCAAACCATGTCAGCTCGAACTCCACCGGAAGCAGCTAGTT TCGGCTCTGGCCTCCAAGTCCACAGTGGAACCAGCCCAGACCCTTCTCCTTAGAAGTGGAAGTAGTGGAGCCCCTGCTCTGGTGGGGCTG CCAGGGGAGACCCCGGGAGCCGGGGAAGGAGGCCGTCCATCCCGTCGACGTAGAACCTCGAGGTTTCTCAAAGAAATTTCCACTCAGGTC TGTTTTCCGAGGCGGCCCCGGCCGGGGTGGATTGGATTTGTCTTTGGTGAACATTGCAATAGAAATCCAATTGGATACGACAACTTGCAC GTATTTTAATAGCGTCATAACTAGAACTGAATTTTGTCTTTATGATTTTTAAAGAAAAGTTTTGTAAATTTCTCTACTGTCTCAGTTTAC ATTTTGTATATTTGTATTTAAATGAAAGTGAGACTTTGAGGGTGTATATTTTCTGTGCAGCCACTGTTAAGCCATGTGTTCCAAGGCATT TTAGCGGGGAGGGGGTTATCAAAAAAAAAAAAATGTGACTCAAGACTTCCAGAGCCTCAAATGAGAAAATGTCTTTATTAAATGTAGAAA >39843_39843_1_INPP5F-GRK5_INPP5F_chr10_121485871_ENST00000361976_GRK5_chr10_121140327_ENST00000392870_length(amino acids)=573AA_BP=27 MELFQAKDHYILQQGERALWCSRRDGGLQLRPDRDYCSLCDKQPIGRLLFRQFCETRPGLECYIQFLDSVAEYEVTPDEKLGEKGKEIMT KYLTPKSPVFIAQVGQDLVSQTEEKLLQKPCKELFSACAQSVHEYLRGEPFHEYLDSMFFDRFLQWKWLERQPVTKNTFRQYRVLGKGGF GEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER ALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGDLIRGRVGTVGYMAPEVLNNQRYGLSPDYWGLGCLIYE MIEGQSPFRGRKEKVKREEVDRRVLETEEVYSHKFSEEAKSICKMLLTKDAKQRLGCQEEGAAEVKRHPFFRNMNFKRLEAGMLDPPFVP DPRAVYCKDVLDIEQFSTVKGVNLDHTDDDFYSKFSTGSVSIPWQNEMIETECFKELNVFGPNGTLPPDLNRNHPPEPPKKGLLQRLFKR -------------------------------------------------------------- >39843_39843_2_INPP5F-GRK5_INPP5F_chr10_121485871_ENST00000369083_GRK5_chr10_121140327_ENST00000392870_length(transcript)=2440nt_BP=263nt TCTCCTCCTACCGGTCGGGTGCCCCGGGGCGTTCCCTCTGCCGCTGCTTCTCGGCGCGGTTCCTACCCGGCCGCTCCCCGAGGCGCGGGC TCTGGCGGCCTCGACCGACTAGGACGCCCCGTGCGCCGCCCGCGGGCCGCCGCCTCCCTGGGCGCGCGGGGCCAGCATGGAGCTCTTCCA AGCCAAGGACCACTACATCCTGCAGCAGGGCGAGCGCGCGCTGTGGTGCAGCCGCCGCGACGGCGGCCTCCAGCTCCGACCCGACAGAGA TTACTGCAGTTTATGTGACAAGCAGCCAATCGGGAGGCTGCTTTTCCGGCAGTTTTGTGAAACCAGGCCTGGGCTGGAGTGTTACATTCA GTTCCTGGACTCCGTGGCAGAATATGAAGTTACTCCAGATGAAAAACTGGGAGAGAAAGGGAAGGAAATTATGACCAAGTACCTCACCCC AAAGTCCCCTGTTTTCATAGCCCAAGTTGGCCAAGACCTGGTCTCCCAGACGGAGGAGAAGCTCCTACAGAAGCCGTGCAAAGAACTCTT TTCTGCCTGTGCACAGTCTGTCCACGAGTACCTGAGGGGAGAACCATTCCACGAATATCTGGACAGCATGTTTTTTGACCGCTTTCTCCA GTGGAAGTGGTTGGAAAGGCAACCGGTGACCAAAAACACTTTCAGGCAGTATCGAGTGCTAGGAAAAGGGGGCTTCGGGGAGGTCTGTGC CTGCCAGGTTCGGGCCACGGGTAAAATGTATGCCTGCAAGCGCTTGGAGAAGAAGAGGATCAAAAAGAGGAAAGGGGAGTCCATGGCCCT CAATGAGAAGCAGATCCTCGAGAAGGTCAACAGTCAGTTTGTGGTCAACCTGGCCTATGCCTACGAGACCAAGGATGCACTGTGCTTGGT CCTGACCATCATGAATGGGGGTGACCTGAAGTTCCACATCTACAACATGGGCAACCCTGGCTTCGAGGAGGAGCGGGCCTTGTTTTATGC GGCAGAGATCCTCTGCGGCTTAGAAGACCTCCACCGTGAGAACACCGTCTACCGAGATCTGAAACCTGAAAACATCCTGTTAGATGATTA TGGCCACATTAGGATCTCAGACCTGGGCTTGGCTGTGAAGATCCCCGAGGGAGACCTGATCCGCGGCCGGGTGGGCACTGTTGGCTACAT GGCTCCAGAGGTCCTGAACAACCAGAGGTACGGCCTGAGCCCCGACTACTGGGGCCTTGGCTGCCTCATCTATGAGATGATCGAGGGCCA GTCGCCGTTCCGCGGCCGCAAGGAGAAGGTGAAGCGGGAGGAGGTGGACCGCCGGGTCCTGGAGACGGAGGAGGTGTACTCCCACAAGTT CTCCGAGGAGGCCAAGTCCATCTGCAAGATGCTGCTCACGAAAGATGCGAAGCAGAGGCTGGGCTGCCAGGAGGAGGGGGCTGCAGAGGT CAAGAGACACCCCTTCTTCAGGAACATGAACTTCAAGCGCTTAGAAGCCGGGATGTTGGACCCTCCCTTCGTTCCAGACCCCCGCGCTGT GTACTGTAAGGACGTGCTGGACATCGAGCAGTTCTCCACTGTGAAGGGCGTCAATCTGGACCACACAGACGACGACTTCTACTCCAAGTT CTCCACGGGCTCTGTGTCCATCCCATGGCAAAACGAGATGATAGAAACAGAATGCTTTAAGGAGCTGAACGTGTTTGGACCTAATGGTAC CCTCCCGCCAGATCTGAACAGAAACCACCCTCCGGAACCGCCCAAGAAAGGGCTGCTCCAGAGACTCTTCAAGCGGCAGCATCAGAACAA TTCCAAGAGTTCGCCCAGCTCCAAGACCAGTTTTAACCACCACATAAACTCAAACCATGTCAGCTCGAACTCCACCGGAAGCAGCTAGTT TCGGCTCTGGCCTCCAAGTCCACAGTGGAACCAGCCCAGACCCTTCTCCTTAGAAGTGGAAGTAGTGGAGCCCCTGCTCTGGTGGGGCTG CCAGGGGAGACCCCGGGAGCCGGGGAAGGAGGCCGTCCATCCCGTCGACGTAGAACCTCGAGGTTTCTCAAAGAAATTTCCACTCAGGTC TGTTTTCCGAGGCGGCCCCGGCCGGGGTGGATTGGATTTGTCTTTGGTGAACATTGCAATAGAAATCCAATTGGATACGACAACTTGCAC GTATTTTAATAGCGTCATAACTAGAACTGAATTTTGTCTTTATGATTTTTAAAGAAAAGTTTTGTAAATTTCTCTACTGTCTCAGTTTAC ATTTTGTATATTTGTATTTAAATGAAAGTGAGACTTTGAGGGTGTATATTTTCTGTGCAGCCACTGTTAAGCCATGTGTTCCAAGGCATT TTAGCGGGGAGGGGGTTATCAAAAAAAAAAAAATGTGACTCAAGACTTCCAGAGCCTCAAATGAGAAAATGTCTTTATTAAATGTAGAAA >39843_39843_2_INPP5F-GRK5_INPP5F_chr10_121485871_ENST00000369083_GRK5_chr10_121140327_ENST00000392870_length(amino acids)=573AA_BP=27 MELFQAKDHYILQQGERALWCSRRDGGLQLRPDRDYCSLCDKQPIGRLLFRQFCETRPGLECYIQFLDSVAEYEVTPDEKLGEKGKEIMT KYLTPKSPVFIAQVGQDLVSQTEEKLLQKPCKELFSACAQSVHEYLRGEPFHEYLDSMFFDRFLQWKWLERQPVTKNTFRQYRVLGKGGF GEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER ALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGDLIRGRVGTVGYMAPEVLNNQRYGLSPDYWGLGCLIYE MIEGQSPFRGRKEKVKREEVDRRVLETEEVYSHKFSEEAKSICKMLLTKDAKQRLGCQEEGAAEVKRHPFFRNMNFKRLEAGMLDPPFVP DPRAVYCKDVLDIEQFSTVKGVNLDHTDDDFYSKFSTGSVSIPWQNEMIETECFKELNVFGPNGTLPPDLNRNHPPEPPKKGLLQRLFKR -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for INPP5F-GRK5 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Tgene | GRK5 | chr10:121485871 | chr10:121140327 | ENST00000392870 | 1 | 16 | 20_39 | 49.333333333333336 | 591.0 | calmodulin |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for INPP5F-GRK5 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for INPP5F-GRK5 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies